CRYO-CELL INTERNATIONAL, INC. (CCEL) Debt Components
- 2026-05-31: Notes Payable, CurrentUSD $195.13K; Long-term DebtUSD $8.28M; Long-Term Debt, Maturity, Year OneUSD $207.59K; Long-Term Debt, Maturity, Year TwoUSD $220.49K.
- 2026-02-28: Notes Payable, CurrentUSD $191.09K; Long-term DebtUSD $8.32M; Long-Term Debt, Maturity, Year OneUSD $204.78K; Long-Term Debt, Maturity, Year TwoUSD $217.12K.
- 2025-11-30: Notes Payable, CurrentUSD $183.65K; Long-term DebtUSD $8.35M; Long-Term Debt, Maturity, Year OneUSD (m); Long-Term Debt, Maturity, Year TwoUSD (m).
- 2025-11-30: Notes Payable, CurrentUSD (m); Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD $183.65K; Long-Term Debt, Maturity, Year TwoUSD $201.99K.
CRYO-CELL INTERNATIONAL, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Notes Payable, Current USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Long-Term Debt, Maturity, after Year Five USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD | Long-term Debt, Excluding Current Maturities USD | Long-term Line of Credit USD | Notes Payable USD | Line of Credit Facility, Maximum Amount Outstanding During Period USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-31 | $195.13K | $8.28M | $207.59K | $220.49K | $234.61K | $249.65K | (m) | (m) | $195.13K | $117.10K | (m) | (m) | (m) | (m) |
| 2026-02-28 | $191.09K | $8.32M | $204.78K | $217.12K | $231.02K | $245.83K | (m) | (m) | $191.09K | $122.21K | (m) | (m) | (m) | (m) |
| 2025-11-30 | $183.65K | $8.35M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-11-30 | (m) | (m) | $183.65K | $201.99K | $213.75K | $227.44K | $242.01K | $7.41M | (m) | $127.34K | (m) | (m) | (m) | (m) |
| 2025-08-31 | $179.19K | $8.39M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-05-31 | $177.60K | $8.42M | $195.13K | $207.59K | $220.49K | $234.61K | (m) | (m) | $177.60K | $137.70K | (m) | (m) | (m) | (m) |
| 2025-02-28 | $178.79K | $8.45M | $191.09K | $204.79K | $217.12K | $231.02K | (m) | (m) | $178.79K | $-142.92K | (m) | (m) | (m) | (m) |
| 2024-11-30 | $170.49K | $8.48M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-11-30 | (m) | (m) | $170.49K | $227.44K | $213.75K | $201.99K | $187.03K | $7.63M | (m) | $148.17K | (m) | (m) | (m) | (m) |
| 2024-08-31 | $174.59K | $8.51M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-05-31 | $171.60K | $8.53M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-02-29 | $168.62K | $8.56M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-11-30 | $165.64K | $8.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-08-31 | $162.66K | $8.63M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-05-31 | $158.46K | $8.66M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-02-28 | $158.46K | $8.71M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-11-30 | $150.53K | $8.73M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-08-31 | $154.25K | $8.76M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-05-31 | $357.84K | $357.84K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $358.43K | (m) |
| 2022-02-28 | $1.13M | $1.13M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.13M | (m) |
| 2021-11-30 | $1.90M | $1.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.91M | (m) |
| 2021-08-31 | $2.66M | $2.66M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.68M | (m) |
| 2021-05-31 | $3.10M | $3.43M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $3.46M | (m) |
| 2021-02-28 | $3.10M | $4.19M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $4.23M | (m) |
| 2020-12-01 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $150.00K |
| 2020-11-30 | $3.10M | $5.94M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $6.01M | (m) |
| 2020-11-30 | (m) | (m) | $3.10M | $2.91M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-08-31 | $3.10M | $6.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $6.78M | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $350.00K | (m) | $150.00K |
| 2020-05-31 | $3.10M | $7.45M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $7.56M | (m) |
| 2020-02-29 | $3.10M | $8.21M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $8.33M | (m) |
| 2019-11-30 | $3.10M | $8.96M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $9.11M | (m) |
| 2019-11-30 | (m) | (m) | $3.10M | $3.10M | $2.91M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-08-31 | $3.10M | $9.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $9.88M | (m) |
| 2019-05-31 | $3.10M | $11.45M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.43M | (m) | $11.66M | (m) |
| 2019-02-28 | $3.10M | $12.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.43M | (m) | $12.43M | (m) |
| 2018-11-30 | $3.10M | $12.94M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $13.21M | (m) |
| 2018-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.43M | (m) | (m) | (m) |
| 2018-11-30 | (m) | (m) | $3.10M | $3.10M | $3.10M | $3.10M | $808.43K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-08-31 | $3.10M | $14.69M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.43M | (m) | $14.98M | (m) |
| 2018-05-31 | $2.00M | $6.35M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.43M | (m) | $6.50M | (m) |
| 2018-02-28 | $2.00M | $6.82M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.43M | (m) | $7.00M | (m) |
| 2017-11-30 | $2.00M | $7.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.43M | (m) | $7.50M | (m) |
| 2017-11-30 | (m) | (m) | $2.00M | $2.00M | $2.00M | $1.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-08-31 | $2.00M | $7.77M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.43M | (m) | $8.00M | (m) |
| 2017-05-31 | $2.00M | $8.89M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.43M | (m) | $9.15M | (m) |
| 2017-02-28 | $2.00M | $9.35M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.43M | (m) | $9.65M | (m) |
| 2016-11-30 | $2.00M | $9.82M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.43M | (m) | $10.15M | (m) |
| 2016-11-30 | (m) | (m) | $2.00M | $2.00M | $2.00M | $2.00M | $2.15M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-08-31 | $2.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.43M | (m) | $0.00 | (m) |
| 2016-05-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.30M | (m) | $0.00 | (m) |
| 2016-02-29 | $309.99K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.30M | (m) | $1.10M | (m) |
| 2015-11-30 | $307.42K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.30M | (m) | $1.18M | (m) |
| 2015-11-30 | (m) | (m) | $307.42K | $323.15K | $339.68K | $206.12K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-08-31 | $303.61K | (m) | (m) | $307.42K | $323.15K | $339.68K | $206.12K | (m) | $74.49K | (m) | $2.30M | (m) | $1.25M | (m) |
| 2015-05-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.30M | (m) | (m) | (m) |
| 2015-02-28 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.30M | (m) | (m) | (m) |
| 2014-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.30M | (m) | (m) | (m) |
| 2014-08-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.30M | (m) | (m) | (m) |
| 2014-05-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.30M | (m) | (m) | (m) |
| 2014-02-28 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.30M | (m) | (m) | (m) |
| 2013-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.30M | (m) | (m) | (m) |
| 2013-08-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.30M | (m) | (m) | (m) |
| 2013-05-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.30M | (m) | (m) | (m) |
| 2013-02-28 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.30M | (m) | (m) | (m) |
| 2012-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.30M | (m) | (m) | (m) |
| 2012-08-31 | $194.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.30M | (m) | (m) | (m) |
| 2012-05-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.65M | (m) | (m) | (m) |
| 2012-02-29 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.85M | (m) | (m) | (m) |
| 2011-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.85M | (m) | (m) | (m) |
| 2011-08-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $3.75M | (m) | (m) | (m) |
| 2010-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $3.75M | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |